Transplanted Human Amniotic Membrane-Derived Mesenchymal Stem Cells Ameliorate Carbon Tetrachloride-Induced Liver Cirrhosis in Mouse
2011

Stem Cells Help Heal Liver Damage in Mice

Sample size: 20 publication 10 minutes Evidence: moderate

Author Information

Author(s): Zhang Ding, Guo Jiang, Min Yue, Miao Deng, Shun

Primary Institution: The Research Center for Bone and Stem Cells, Nanjing Medical University, Nanjing, China

Hypothesis

Can human amniotic membrane-derived mesenchymal stem cells (hAMCs) reduce liver fibrosis in a mouse model of cirrhosis?

Conclusion

Transplantation of hAMCs significantly decreased fibrosis formation and progression in CCl4-induced cirrhosis in mice.

Supporting Evidence

  • hAMCs transplantation reduced liver fibrosis by 1.5-fold compared to control.
  • Serum ALT and AST levels were significantly lower in the hAMCs group.
  • hAMCs suppressed activation of hepatic stellate cells.
  • Transplantation promoted hepatocyte regeneration and reduced apoptosis.
  • hAMCs differentiated into hepatocyte-like cells in the injured liver.

Takeaway

Scientists found that special cells from the amniotic membrane can help heal damaged livers in mice, making them healthier.

Methodology

Mice with liver cirrhosis were treated with hAMCs or saline, and various liver functions and histological analyses were performed.

Limitations

The study was conducted in mice, and results may not directly translate to humans.

Participant Demographics

C57Bl/6J mice, aged 4-6 weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016789

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication